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A B S T R A C T
Epinephrine is a frequently used catecholamine, particularly in emergencies and during resuscitation
attempts. It is not without side effects. We report a rare case of epinephrine-induced cardiomyopathy.
Epinephrine was administered for bradycardia in our patient. He was treated conservatively and
responded well to the treatment. Through our work we wish to highlight this adverse cardiac effect of
epinephrine. We hope to increase awareness among residents and practicing physicians while using
epinephrine.
<Learning objective: Epinephrine, although a lifesaving drug, has adverse side effects. Dosages and
routes of administration determine its toxicity. Exogenous catecholamines can cause presentations
similar to takotsubo cardiomyopathy. Management is supportive and the outcomes are good.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Epinephrine is a catecholamine, used in the treatment of a
number of medical conditions, mostly emergent, and life-
threatening. Takotsubo cardiomyopathy (TCM) is attributed to
excess catecholamines, and differential regional susceptibility has
been attributed to its characteristic wall motion abnormalities. We
describe a rare case of stress cardiomyopathy with wall motions
similar to TCM caused by excess exogenous catecholamine
administration.
Case report
A 49-year-old Hispanic male drove himself to our hospital after
noticing that his home blood pressure monitor was unable to
record his heart rate. He complained of atypical chest pain,
palpitations, generalized weakness, and light-headedness. In the
emergency room, he appeared pale and diaphoretic with a blood
pressure of 188/82 mmHg and pulse 33 beats per minute (bpm).
His electrocardiogram (ECG) showed sinus rhythm at 66 bpm with
2:1 atrioventricular conduction and left bundle branch block (AVB;
PR 190 ms and QRS 162 ms). He was administered 2 doses of
atropine intravenously, 0.5 mg each, over 10 min. The sinus rate
rose to 90 bpm but 2:1 AVB persisted, resulting in pulse of 45 bpm.* Corresponding author at: 2905, Tangerine Avenue, Mt. Vernon, IL 62864, USA.
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(1:10,000) intravenously. His pulse increased to 120 bpm and
the ECG showed sinus tachycardia with intermittent left bundle
branch block and runs of non-sustained ventricular tachycardia
(Fig. 1). He was admitted to the medical intensive care unit (MICU)
for further management. His blood work revealed an elevated
troponin at 7.32 ng/ml. Coronary angiography the following day
revealed patent coronary arteries (Figs. 2 and 3) with mid-anterior
wall dyskinesis (Fig. 4) consistent with TCM. It was hypothesized
that TCM had resulted from the infusion of epinephrine. He was
observed. Neither beta-blockers nor antithrombotic agents were
given. Echocardiogram on the 2nd hospital day revealed complete
resolution of the wall motion abnormalities. His infra-nodal AVB
was treated with permanent pacemaker implantation.
Discussion
TCM is deﬁned as temporary ventricular stunning of myocardial
contraction in the absence of coronary artery disease. The most
common abnormality is left ventricular apical ballooning that does
not conform to a single coronary artery distribution. Patients
typically present with chest pain, ECG changes, and elevated
cardiac enzymes [1]. ECG abnormalities can include ST segment
elevation in the anterior leads, deep T-wave inversions with
nonspeciﬁc ST-T wave changes, or a prolonged QT interval [2]. TCM
affects 1–2% of patients presenting to the Emergency Department
with symptoms of acute coronary syndrome (ACS) and is most
commonly seen in post-menopausal women [3]. reserved.
Fig. 1. Electrocardiogram (ECG) at presentation, and after epinephrine injection.
Fig. 2. Normal right coronary artery. Fig. 3. Normal left coronary artery.
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conﬂicting ﬁndings in the literature. Most TCM cases are believed
to be trigged by either emotional or physical stressors. One of the
leading explanations is that a stressor causes catecholamine
excess, with overstimulation of the sympathetic nervous system.Fig. 4. Mid anterior hypokinesis (black arrow) noted on left ventriculogram on endThis, in turn, leads to myocardial wall stunning and apical
ballooning [4,5]. The variable distribution of catecholamine
receptors across the length of the left ventricle, from base to
apex, is believed to be responsible for this characteristic TCM-
related left ventricular dysfunction. Studies have suggested that systole ventriculogram, normal end diastole ventriculogram.
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eceptor ‘‘signal trafﬁcking’’ occurs, with further stimulation of
adrenoreceptors resulting in a negative inotropic effect, rather
than a positive one. Thus, an intense sympathetic surge may cause
hyperkinesis of the left ventricular basal segments with ballooning
of the left ventricular apex [6]. Other regional wall motion
abnormalities, such as mid-chamber akinesis, sparing the apex and
base, have also been described. In addition, catecholamine excess is
associated with direct myocardial toxicity. This is thought to be the
mechanism of cardiomyopathy seen in patients with pheochro-
mocytoma [7].
Catecholamine surges from an exogenous source can cause a
similar presentation as TCM. Epinephrine is a frequently used
catecholamine. It acts by stimulating alpha, beta-1, and beta-2-
adrenergic receptors. Epinephrine is administered intravenously
(IV) in doses of 0.1 mg (1:10,000) in hypersensitivity reactions. Per
advanced cardiac life support protocol, an IV bolus of 1 mg
epinephrine (1:10 000) every 3–5 min may be given [8]. In cases of
hypotension or shock, an IV infusion of epinephrine with doses of
0.1–0.5 mg/kg/min has been used. Relative to these recommended
epinephrine doses, the dose given to our patient was fairly high.
Although it may be beneﬁcial in cases of life-threatening illness,
the side effects of epinephrine can be severe, including angina,
cardiac arrhythmia, and sudden death. Both IV and intramuscular
epinephrine have been implicated in coronary spasm-mediated
acute myocardial infarction (AMI). Catecholamine-induced car-
diomyopathy has been reported, although not as frequently as AMI
due to catecholamines. In fact, the Mayo Criteria for the diagnosis
of TCM recommend that pheochromocytoma be excluded before
TCM is diagnosed [9]. Although catecholamine levels were not
measured in our patient, it is likely that the IV dose he received
resulted in transiently high levels akin to those seen in patients
with catecholamine-secreting tumors. This likely resulted in
catecholamine-associated toxicity to the heart, and a TCM-like
presentation.
The mainstay of treatment for TCM is supportive, and the
prognosis is generally good. No randomized trials have examined
the efﬁcacy of various medications; however beta-blockers,
angiotensin-converting enzyme inhibitors, and angiotensin II
receptor blocking agents are being used in routine clinical practice
[10]. No such drugs were given to our patient.
This case highlights the potential adverse side effects of
epinephrine use – exogenous epinephrine may cause TCM andclinicians should be aware of the possible ramiﬁcations of using
this ‘‘life-saving’’ drug.
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